Dopamine agonists

P. Tuite, B. Ebbitt

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations

Abstract

Dopamine agonists provide an effective means of treating early, middle, and late stages of Parkinson's disease. This article outlines the advantages and disadvantages of dopamine agonists as compared with levodopa therapy. The features and costs of the four Food and Drug Administration-approved agonists (bromocriptine, pergolide, pramipexole, and ropinirole) and apomorphine, another agonist presently under investigation, are discussed.

Original languageEnglish (US)
Pages (from-to)9-14
Number of pages6
JournalSeminars in Neurology
Volume21
Issue number1
DOIs
StatePublished - 2001

Keywords

  • Dopamine agonists
  • Parkinson's disease
  • Parkinson's disease treatment

Fingerprint Dive into the research topics of 'Dopamine agonists'. Together they form a unique fingerprint.

Cite this